Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158
2020 ◽
Vol Volume 13
◽
pp. 423-431
◽
Keyword(s):
2011 ◽
Vol 94
(2)
◽
pp. 217-224
◽